Cerebral Small Vessel Disease Clinical Trial
Official title:
Correlation Between Deep Medullary Veins and Cognitive Dysfunction in Cerebral Small Vessel Disease
This study aims to obtain the characteristics of cognitive impairment and imaging characteristics of patients with Cerebral small vessel disease (CSVD) through comprehensive and standardized neuropsychological assessment and multimodal imaging examination. The focus is to obtain the characteristics of cognitive impairment and imaging characteristics of patients with CSVD through 3.0T MRI SWI sequence. deep medullary veins (DMVs) were measured. To compare the demographic data, hematological indexes, imaging scores and the number of DMVs between CSVD groups with and without cognitive impairment, and to explore the correlation between deep medullary veins and cognitive dysfunction in cerebral small vessel disease.
This study aims to obtain the characteristics of cognitive impairment and imaging characteristics of patients with Cerebral small vessel disease (CSVD) by conducting comprehensive and standardized neuropsychological assessment and multimodal imaging examination. deep medullary veins (DMVs) were measured. The demographic data, hematological indexes, imaging scores and the number of DMVs were compared between the CSVD group with and without cognitive impairment, and the risk factors for cognitive impairment in CSVD were analyzed to explore whether DMVs could be an independent risk factor for cognitive impairment in CSVD. To establish a multiple model for the risk prediction of cognitive impairment in CSVD, and to understand whether the prediction model combined with the number of DMVs has a better prediction effect on cognitive impairment in CSVD. In order to find new imaging markers of cognitive impairment in CSVD, and provide evidence for early detection and intervention of cognitive impairment in clinical CSVD. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT02169739 -
Remote Preconditioning Over Time To Empower Cerebral Tissue
|
N/A | |
| Recruiting |
NCT05356104 -
GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD)
|
Phase 2 | |
| Recruiting |
NCT05374005 -
The Impact of Excessive Dietary Sodium on Brain Health
|
||
| Completed |
NCT01658306 -
Clinical Trial on Remote Ischemic Preconditioning and Cerebral Small Vessel Disease
|
Phase 3 | |
| Active, not recruiting |
NCT01932203 -
Efficacy Study of Cilostazol and Aspirin on Cerebral Small Vessel Disease
|
Phase 4 | |
| Completed |
NCT02033291 -
Blood-brain Barrier Quantification in Cerebral Small Vessel Disease
|
N/A |